JELD-WEN heads into its Q1 2026 earnings call this morning with short sellers firmly in control of the narrative.
Short interest has become the dominant story. Shares short climbed 35.5% in the past week alone, pushing to nearly 12% of the free float — the highest level in over a month. The rise accelerated sharply after April 23, when short interest jumped from roughly 7.5 million shares to above 9 million in a single session. Meanwhile the ORTEX short score has moved up to 57.8 from just below 50 two weeks ago, ranking the stock in just the 8th percentile of its universe for short-interest pressure. That's a meaningful shift in conviction from the bear side in a very compressed timeframe.
Options positioning reinforces the bearish tilt. The put/call ratio hit 0.54 on Monday — the highest reading of the past 52 weeks, and well above its 20-day average of 0.36. At 1.6 standard deviations above the mean, demand for downside protection has never been higher in the past year. The stock itself closed Monday at $1.39, down 4.1% on the day and off 9.2% over the week, even after a 26% bounce over the prior month. The borrow market, by contrast, remains wide open: cost to borrow is just 0.58%, and borrow availability is ample, meaning new short positions face no meaningful entry friction.
The fundamental debate is equally pointed. Bears focus on a string of downward estimate revisions — FY26 revenue expectations were cut to $3.29 billion against a prior $3.40 billion estimate, while adjusted EBITDA for FY25 was slashed to $145 million from $205 million — signalling persistent margin compression on top of organic sales declines. Bulls counter that any recovery in housing starts, home improvement spending, or North American pricing could drive meaningful operating leverage from a depressed base, particularly after Q1 already squeezed past modest revenue expectations at $776 million. Analyst sentiment, last updated in early April, sits neutral across the board — Goldman Sachs, Barclays, and Jefferies all hold neutral or equal-weight ratings, with Goldman's January target cut to $3.25 the most recent action from a major firm. The mean price target of $2.19 sits well above the current $1.39 price, but the direction of revisions has been uniformly lower for months. One notable institutional data point: Bank of Nova Scotia added 6.2 million shares in Q1, lifting its stake to 10.8%, making it the second-largest holder — a meaningful contrarian bet against the bear flow.
The Q1 print is therefore a test of whether management's cost structure can hold as volume falls, and whether any guidance update credibly addresses the EBITDA gap that analysts have been steadily repricing downward since mid-2025.
See the live data behind this article on ORTEX.
Open JELD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
